Back
Achieve Life Sciences Vs. ENDRA Life Sciences Industry Stock Comparison
Buy
52
ACHV
Achieve Life Sciences
Last Price:
4.74
Seasonality Move:
5.03%
Sell
27
NDRA
ENDRA Life Sciences
Last Price:
0.32
Seasonality Move:
4.69%
Buy
52
Achieve Life Sciences (ACHV)
is a Buy
Is Achieve Life Sciences a Buy, Sell or Hold?
- The current Achieve Life Sciences [ACHV] share price is $4.75. The Score for ACHV is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ACHV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
ENDRA Life Sciences (NDRA)
is a Sell
Is ENDRA Life Sciences a Buy, Sell or Hold?
- The current ENDRA Life Sciences [NDRA] share price is $0.31. The Score for NDRA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NDRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACHV Stock Price Chart
What is Achieve Life Sciences's stock price today?
-
The Achieve Life Sciences share price today is $4.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACHV is experiencing buying pressure, which is a positive indicator for future bullish movement.
NDRA Stock Price Chart
What is ENDRA Life Sciences's stock price today?
-
The ENDRA Life Sciences share price today is $0.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NDRA is experiencing slight selling pressure.
ACHV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 58.59 | Buy |
| Chaikin Money Flow: | 80352 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.39 - 4.63) | Buy |
| Bollinger Bands (100): | (3.98 - 4.74) | Buy |
NDRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 36.37 | Sell |
| Chaikin Money Flow: | -4812 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.25 - 0.35) | Buy |
| Bollinger Bands (100): | (0.48 - 1.5) | Sell |
ACHV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.61 | Buy |
| 20-day SMA: | 4.52 | Buy |
| 50-day SMA: | 4.5 | Buy |
| 200-day SMA: | 4.56 | Buy |
| 8-day EMA: | 4.63 | Buy |
| 20-day EMA: | 4.56 | Buy |
| 50-day EMA: | 4.51 | Buy |
| 200-day EMA: | 4.65 | Buy |
NDRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.3 | Buy |
| 20-day SMA: | 0.29 | Buy |
| 50-day SMA: | 0.64 | Sell |
| 200-day SMA: | 1.05 | Sell |
| 8-day EMA: | 0.3 | Buy |
| 20-day EMA: | 0.34 | Sell |
| 50-day EMA: | 0.57 | Sell |
| 200-day EMA: | 1.27 | Sell |
Achieve Life Sciences Earnings Growth & ACHV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.49 per share, and an increase next year of $0.10 per share.
ENDRA Life Sciences Earnings Growth & NDRA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.79 per share, and an increase next year of $0.02 per share.
Achieve Life Sciences Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ENDRA Life Sciences Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||